Mission Statement

Alcoholic hepatitis is a very severe liver disease in which the current available therapies are not fully effective. To develop new effective therapies, we first have to identify the main mechanisms of the disease. The InTeam initiative was created to fill this gap and provide a new framework for the development of drugs capable of curing alcoholic hepatitis.

The key components of our consortium:

Our multidisciplinary approach includes 10 clinical centers in the US, Mexico and Europe, three different scientific projects, and an Animal Core to test new therapies.